Increased Fibroblast Growth Factor 21 in Nonalcoholic Fatty Liver Disease

被引：0
|
作者：
Dushay, Jody
Chui, Patricia
Gopalakrishnan, Gosala S.
Varelarey, Marta
Crawley, Meghan
Fisher, Ffolliott M.
Badman, Michael K.
Martinez-Chantar, Maria L.
Maratos-Flier, Eleftheria
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A414 / A414
页数：1
相关论文
共 50 条
  • [31] Growth hormone and nonalcoholic fatty liver disease
    Ma, Ingrid L.
    Stanley, Takara L.
    IMMUNOMETABOLISM, 2023, 5 (03)
  • [32] The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy
    Liu, Jia
    Xu, Yuan
    Hu, Yanjin
    Wang, Guang
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (03): : 380 - 390
  • [33] Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease
    Tucker, Bradley
    McClelland, Robyn L.
    Allison, Matthew A.
    Budoff, Matthew J.
    Wu, Ben J.
    Barter, Philip J.
    Rye, Kerry-Anne
    Ong, Kwok Leung
    ATHEROSCLEROSIS, 2020, 299 : 38 - 44
  • [34] Growth differentiation factor 11 promotes progression of nonalcoholic fatty liver disease
    Frohlich, Jan
    Kovacovicova, Kristina
    Mazza, Tommaso
    Foti, Michelangelo
    Sobolewski, Cyril
    Peyrou, Marion
    Villarroya, Francesc
    Cervello, Melchiorre
    Bonomini, Francesca
    Vinciguerra, Manlio
    JOURNAL OF HEPATOLOGY, 2020, 73 : S665 - S666
  • [35] Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease
    Peng, Yue
    Pei, Qiongfei
    Feng, Siqi
    Su, Ya
    Liu, Ruixi
    Yi, Qijian
    Guo, Pengfei
    CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 19 (04) : 457 - 462
  • [36] Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease
    Yue Peng
    Qiongfei Pei
    Siqi Feng
    Ya Su
    Ruixi Liu
    Qijian Yi
    Pengfei Guo
    Clinical and Experimental Medicine, 2019, 19 : 457 - 462
  • [37] The role of fibroblast growth factor 19 regulation in diabetes remission and nonalcoholic fatty liver disease improvement after sleeve gastrectomy
    Chen, Chih-Yen
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 470 - 470
  • [38] CIRCULATING FIBROBLAST GROWTH FACOTR-21 (FGF-21): A BIOMARKER OF SUBCLINICAL ATHEROSCLEROSIS IN OBESE YOUTH WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)?
    Bacha, Fida
    Tomsa, Anca
    Bartz, Sara K.
    Chu, David Zili
    Barlow, Sarah
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 154 - 154
  • [39] Is nonalcoholic fatty liver disease driving the increased incidence of liver cancer?
    Mahabir, Somdat
    CANCER, 2016, 122 (14) : 2277 - 2278
  • [40] Increased brain-derived neurotrophic factor in the serum of persons with nonalcoholic fatty liver disease
    Hattori, Yuji
    Yamada, Hiroya
    Munetsuna, Eiji
    Ando, Yoshitaka
    Mizuno, Genki
    Fujii, Ryosuke
    Tsuboi, Yoshiki
    Ichino, Naohiro
    Osakabe, Keisuke
    Sugimoto, Keiko
    Ishikawa, Hiroaki
    Ohashi, Koji
    Suzuki, Koji
    ENDOCRINE JOURNAL, 2022, 69 (08) : 999 - 1006
12345